Daiwa SB Investments’s Edwards Lifesciences EW Stock Holding History

Daiwa SB Investments’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-61,548	Closed	-$1.46M	–	175
2015 Q1	$1.46M	Sell	61,548 -2,256	-4%	-$50.6K	0.26%	89
2014 Q4	$1.35M	Sell	63,804 -76,044	-54%	-$1.53M	0.22%	92
2014 Q3	$2.38M	Sell	139,848 -2,754	-2%	-$43.5K	0.3%	80
2014 Q2	$2.04M	Buy	+142,602	New	+$1.93M	0.26%	92

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Daiwa SB Investments's EW Position: Q2 2015 in Review

Daiwa SB Investments sold out of Edwards Lifesciences (EW) in Q2 2015, closing a stake of 61,548 shares — an estimated $1.46M sold.

Daiwa SB Investments first reported a position in EW in Q2 2014 and held it in 4 quarters. The position peaked at $2.38M in Q3 2014. 578 funds tracked by Wall St. Rank hold EW as of Q2 2015.

Daiwa SB Investments reported no remaining Edwards Lifesciences position as of Q2 2015 after selling out during the quarter.
Daiwa SB Investments sold 61,548 Edwards Lifesciences shares in Q2 2015, an estimated $1.46M.
Daiwa SB Investments first reported a position in Edwards Lifesciences in Q2 2014 and held it in 4 quarters.
Daiwa SB Investments's Edwards Lifesciences position peaked at $2.38M in Q3 2014.
578 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2015.

Based on Daiwa SB Investments's 13F filing for Q2 2015, filed 10 Jul 2015.